Trial intelligence / Profile preview

PK and Safety of Diazepam Buccal Film in Pediatric Epilepsy

NCT03222349Phase 2Completed

Sponsor
Aquestive Therapeutics
Start
Aug 2017
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of libervant in epilepsy, sponsored by Aquestive Therapeutics. Started Aug 2017; status: completed.

02

Drugs

libervant
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT03222349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03222349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call